CBER Will Staff Up With 100 More Reviewers ‘By Hook Or By Crook,’ Marks Says
Executive Summary
US biologics center is getting back to regular business now that COVID-19 work is subsiding; director Marks credits acting commissioner Woodcock with using all available mechanisms to staff up.